These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 21154342)

  • 1. Prophylactic methylxanthines for endotracheal extubation in preterm infants.
    Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD000139. PubMed ID: 21154342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic methylxanthines for extubation in preterm infants.
    Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2003; (1):CD000139. PubMed ID: 12535389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic methylxanthine for extubation in preterm infants.
    Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2000; (2):CD000139. PubMed ID: 10796303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation.
    Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2000; 2000(3):CD001966. PubMed ID: 10908519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylxanthine treatment for apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD000140. PubMed ID: 21154343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxapram for the prevention and treatment of apnea in preterm infants.
    Evans S; Avdic E; Pessano S; Fiander M; Soll R; Bruschettini M
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD014145. PubMed ID: 37877431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylxanthine for the prevention and treatment of apnea in preterm infants.
    Marques KA; Bruschettini M; Roehr CC; Davis PG; Fiander M; Soll R
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013830. PubMed ID: 37905735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation.
    Lemyre B; Davis PG; De Paoli AG; Kirpalani H
    Cochrane Database Syst Rev; 2014 Sep; (9):CD003212. PubMed ID: 25188554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants.
    Moresco L; Sjögren A; Marques KA; Soll R; Bruschettini M
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD015462. PubMed ID: 37791592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extubation from low-rate intermittent positive airways pressure versus extubation after a trial of endotracheal continuous positive airways pressure in intubated preterm infants.
    Davis PG; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2001; (4):CD001078. PubMed ID: 11687097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic methylxanthine for preventing of apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2000; (2):CD000432. PubMed ID: 10796361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000140. PubMed ID: 10796304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants.
    Davis PG; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2003; (2):CD000143. PubMed ID: 12804388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-extubation prophylactic nasal continuous positive airway pressure in preterm infants: systematic review and meta-analysis.
    Davis P; Henderson-Smart D
    J Paediatr Child Health; 1999 Aug; 35(4):367-71. PubMed ID: 10457294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants.
    Davis PG; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; (3):CD000143. PubMed ID: 10908461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous distending pressure for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2001; (3):CD000140. PubMed ID: 11686952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nasal continuous positive airway pressure immediately after extubation for preventing morbidity in preterm infants.
    Ho JJ; Kidman AM; Chua B; Chang G; Fiander M; Davis PG
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD000143. PubMed ID: 39392114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extubation from low-rate intermittent positive airways pressure versus extubation after a trial of endotracheal continuous positive airways pressure in intubated preterm infants.
    Davis PG; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; 2001(2):CD001078. PubMed ID: 10796244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.